BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 21428773)

  • 41. [Chronic bronchitis. Gold standard from the internet].
    MMW Fortschr Med; 2001 Jun; 143(23):47. PubMed ID: 11460425
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
    MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
    [No Abstract]   [Full Text] [Related]  

  • 43. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
    López-Campos JL
    Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Something old, something new, something borrowed. COPD treatment today.
    Goldman CA; Robinson EM; Goldman MD
    Adv Nurse Pract; 2006 Feb; 14(2):49-51, 61. PubMed ID: 16471309
    [No Abstract]   [Full Text] [Related]  

  • 46. New evidence in pulmonary and preventive medicine.
    Dilaghi B; Modesti PA; Conti AA; Nozzoli C
    Intern Emerg Med; 2010 Apr; 5(2):157-9. PubMed ID: 20333483
    [No Abstract]   [Full Text] [Related]  

  • 47. How much lift to the UPLIFT study?
    Mohapatra PR
    Lancet; 2010 Jan; 375(9710):197-8; author reply 198. PubMed ID: 20109917
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Often test the lungs of your patients! "Each patient should know his FEV1 value"].
    MMW Fortschr Med; 2003 May; 145(19):57. PubMed ID: 12813989
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP
    Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do we need three players in COPD treatment?
    Maestrelli P; Mason P; Costa F; Paggiaro P
    Respiration; 2013; 86(4):275-6. PubMed ID: 23988429
    [No Abstract]   [Full Text] [Related]  

  • 54. Prevention of death in COPD.
    La Vecchia C; Fabbri LM
    N Engl J Med; 2007 May; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
    [No Abstract]   [Full Text] [Related]  

  • 55. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of chronic obstructive pulmonary disease.
    Barr RG
    JAMA; 2004 Mar; 291(9):1066-7; author reply 1067. PubMed ID: 14996770
    [No Abstract]   [Full Text] [Related]  

  • 57. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids.
    Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW
    Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec; 16(92):257-8. PubMed ID: 18092426
    [No Abstract]   [Full Text] [Related]  

  • 59. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tiotropium in the management of chronic obstructive pulmonary disease.
    Rees PJ
    Eur Respir J; 2002 Feb; 19(2):205-6. PubMed ID: 11865999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.